506(b) Private Placement · Accredited Investors Only

Regenerative Medicine.
National Private Expansion.

A physician-led longevity and performance platform building company-owned locations nationwide — $3.25M 506(b) SAFE at $10M pre-money. Licensed in 48 states. Physical locations and online retail launching simultaneously. Targeting $52M revenue and a $100–180M exit by 2030.

🔬
Backed by a Clinical Advisory Ecosystem
USMLE100 · SelfHealth.health · Fulcrum Performance Labs · Auvum.bio — clinical trials, nationwide testing, IP, and vetted product supply.
Access Data Room for full details
📋
Execute NDA & Request Access
Accredited investors — complete your profile, execute our NDA, and receive secure data room credentials.
Begin registration →
🔐
Enter Investor Data Room
Access confidential offering documents, financial projections, pitch deck, and due diligence materials.
Enter with credentials →
$3.25M
Round 1 Raise
$10M
Pre-Money Valuation
20%
SAFE Discount
$52M
Year 5 Revenue Target
$180M
Exit Target (2030)
01
Investment Thesis

Built for the $180 Billion Longevity Market

Four structural advantages that compound as the network scales — creating a defensible, physician-led platform competitors cannot easily replicate.

$52M
Year 5 Revenue
Company-owned national expansion — from current operating locations to 55 by 2030, generating $52M in consolidated revenue across physical clinics and online retail.
48
States Licensed
CMO Dr. Patel holds active medical licenses in 48 states — enabling rapid deployment of company-owned locations without the delays of new licensure.
$180M
Exit Valuation Target
$100–180M exit range at 10–15× EBITDA within a 5-year horizon. Comparable physician-owned healthcare networks have transacted at premium multiples.
506(b)
Instrument & Structure
SAFE note at $10M pre-money with 20% discount. MSO-compliant, physician-owned structure across all regulated markets.
02
Platform Architecture
Regen Wellness

Three Formats.
One National Platform.

RegenHealthMD is building a vertically integrated, company-owned national network — physical clinics, performance centers, and online retail launching simultaneously across licensed markets.

Tier 1 · Operating Now
Regenerative Medical Clinic
~1,000 sq ft · $300K avg annual revenue · Satellite clinic model · NYC & Salt Lake City active · 5 additional markets at raise close · SelfHealth.health on-site testing integrated
Tier 2 · Launching Q3 2026
Regen Wellness & Performance Center
3,500–4,000 sq ft · $900K avg annual revenue · Full-service wellness, IV therapy & physical performance · Fulcrum IP & Dr. Morris protocols embedded · Online retail co-launching
Tier 3 · Under Evaluation
Aethera Wellness Institute
80,516–320,000 sq ft (3 development options) · Wynwood Miami Opportunity Zone · $8M avg annual revenue · Hotel/resort longevity concept
Clinical & Advisory Partners
USMLE100 · Dr. Ali Khan, MD
Overseeing clinical trials and IRB protocols · Advising on medical testing standards · 600+ physicians trained · Research published alongside SpaceX team
SelfHealth.health
Clinical medical testing nationwide at every RegenHealthMD location · ~40% margin revenue stream · Customized panels · IRB-integrated
Fulcrum Performance Labs · Dr. Morris
Proprietary IP embedded at every location · NovaKey™ + SSBreath™ / The Morris Method™ · Physical performance programs for patients and athletes
Auvum.bio
Vetted product supply with full chain of custody · Early access to emerging technologies and therapies · Supporting online retail and in-clinic dispensing
03
Geographic Expansion

7 Markets at Close.
55 Locations by 2030.

Capital deployment at close activates company-owned clinics across seven strategic markets simultaneously. 48-state medical licensure via CMO Dr. Patel enables rapid entry — no franchise delays, no third-party operators. Physical locations and online retail launch together in each market.

New York City
● Flagship — Operating
Salt Lake City
● Soft Open — April 2026
Nashville, TN
Opening at raise close
Austin, TX
Opening at raise close
Miami, FL
Opening at raise close
Bay Area, CA
Opening at raise close
Boston, MA
Opening at raise close
7
Year 1 Locations
55
Year 5 Locations
$52M
Year 5 Revenue
$21M
Year 5 EBITDA
Future Vision · Under Evaluation

Aethera Wellness Institute

A luxury longevity resort and hotel concept on a 0.48-acre Wynwood Miami Qualified Opportunity Zone parcel — three development options from 80,516 to 320,000 sq ft. Medical tourism, elite recovery, and regenerative science at institutional scale.

Explore Aethera Club →
04
Investor Relations

Speak with a Project Specialist

Schedule a 30-minute private call with a member of our investor relations team. A project specialist will walk you through the offering, answer your questions, and help you evaluate fit. Available Monday through Friday during the hours below.

✉
office@regenhealthmd.com
📋
Jaye Patel — Director of Business Development
📋
Execute NDA & Request Access
Submit your investor profile and execute our non-disclosure agreement to receive secure data room credentials.
🔐
Access Investor Data Room
Existing credentialed investors — enter your secure access code to view all offering materials.
Available Hours — Eastern Time
Monday – Friday10:00 AM – 3:00 PM
Monday – Friday6:00 PM – 9:00 PM
🔐
Investor Data Room Access
Enter your secure access code. Contact our investor relations team if you require credentials.
Access code not recognized. Please contact investor relations to request credentials.
First time? Execute NDA to request access →
📋
Investor Registration
Step 1 of 2 — Complete your investor profile. You will then review and execute our NDA to receive data room access.
Please complete your name and email address to continue.
All prospective investors must be accredited. Information is kept strictly confidential.
📅
Speak with a Project Specialist
Select your preferred time for a 30-minute call with a member of our investor relations team. A specialist will review the offering and answer your questions. Available Monday–Friday, 10am–3pm & 6pm–9pm ET.